An animal model for acute and persistent Epstein-Barr virus infection
about
Simian homologues of Epstein-Barr virusComplete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model.The criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiationTick-borne encephalitis virus replication, intracellular trafficking, and pathogenicity in human intestinal Caco-2 cell monolayersNon-human primate model of Kaposi's sarcoma-associated herpesvirus infectionInhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells.Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptovirusesProgress, prospects, and problems in Epstein-Barr virus vaccine development.Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses.Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.Simian herpesviruses and their risk to humans.Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challengeKIR3DL01 recognition of Bw4 ligands in the rhesus macaque: maintenance of Bw4 specificity since the divergence of apes and Old World monkeysEpstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy.The immunology of Epstein-Barr virus infectionComplete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.Humanized mouse models of epstein-barr virus infection and associated diseases.An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS.Modeling EBV infection and pathogenesis in new-generation humanized mice.Epstein-barr virus vaccines.Epstein-Barr virus vaccine: a cytotoxic T-cell-based approach.Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.T cell-based therapies for EBV-associated malignancies.Host Range Restriction of Epstein-Barr Virus and Related LymphocryptovirusesMurine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes.Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus MacaquesThe need and challenges for development of an Epstein-Barr virus vaccineDiagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature.Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaquesImpact of infections and normal flora in nonhuman primates on drug development.Macaque models of human infectious disease.Noncoding RNAs produced by oncogenic human herpesviruses.Comparative pathobiology of macaque lymphocryptoviruses.Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.Overview of known non-human primate pathogens with potential to affect colonies used for toxicity testing.Herpesvirus infections of laboratory macaques.
P2860
Q24522326-ED384A44-3DB9-4EB0-82CE-E6F2519CE914Q24540310-CF7A197C-DAC6-42F9-8C45-C8F2F6C2CE5CQ26853527-44EFAA2A-A150-42F9-8EF7-DFAD123ABAFCQ27333771-92A84ACE-41A0-47AA-AA53-C895CE1541E9Q33508240-500C0FF2-2D97-4A9A-A980-217967132EBCQ33649532-09EBCCA2-72DA-4E72-A0A1-85AA67D9B389Q33653017-77ADD5F4-3237-46C2-9EAA-C31EC34416C2Q33784012-5711A113-038E-49F9-A616-0FEEBF62BC6CQ33795078-308C15B6-3181-4090-AC63-EF87D270244CQ33812640-35738DF9-AA16-4EEA-8994-B120551CB915Q33825437-C5E092EE-BAE5-475C-A5B5-6336BCB35BABQ33866311-A1D2FABA-EB1F-4E5B-BBBA-5860AB5C84B6Q33888548-81E05A07-E3EA-418A-9298-059A0E1B01B6Q34058118-AEE28ADC-41A6-4901-AD11-AE6440C6D8F6Q34172209-BAD5172F-BF28-4B51-80CE-17BCD01A16E4Q34180551-550ACF87-207C-4471-9224-1AEAC02E76CDQ34225567-5DACDC4F-D502-47C3-BDBD-7578EA8A3D8BQ34360303-4BB618A6-B211-44A1-9CDA-49085E846198Q34533579-19EE060A-DA05-4279-BA4D-60C902F2411FQ34539785-2DBF52AC-3E40-4A47-956F-7858019F1ECBQ34977168-A7072846-3A0C-49B6-BE92-F784A9DD3D21Q35040650-3B1D049C-C8DC-448E-B17A-E8B5846907CCQ35053650-91454F92-DF1B-46C1-B043-87ACF19B4E73Q35193505-6A05AF88-28D2-4B13-B986-7D24BCF31F95Q35291650-AFB5D613-24BC-49A1-B08F-5D54A8E40F06Q35609768-581CBD13-456F-4B28-83A6-3C26386572C7Q35913939-A27A8D74-C452-4366-B97C-13A82EA50E74Q36398571-7AF8DEA9-658F-4F5A-8C28-3DFEB1EE35CDQ36481549-8707593F-613E-44E0-A2D0-38CA3673EC9CQ36795587-9D3C103A-6C55-4EAE-8E4D-35AFAFF6C75FQ36846805-2E40FD39-8EAB-4D64-A11B-C251D1908CD2Q37010731-E77A1F1D-577F-41D5-A76F-ACB75B024171Q37036688-3CE55977-E6F9-4F70-A520-B41FB4533048Q37103531-42658F2E-DF8F-4296-982C-2E3BBAF89ABCQ37103536-C3899D33-8B24-4E3C-A000-E9832BD1D2DEQ37165298-02BB398F-E8B5-4677-B43B-2C3194A1FC11Q37243867-2D537432-F7B9-4285-8658-2D203EB6EE3AQ37336847-97B6A57C-D4C6-4998-A987-60F3A60CEF87Q37631601-8DB50C49-BFDF-4A59-BF41-B2EBFA03D00DQ37648751-04151FBC-8D15-4800-A730-CEE316EA1F60
P2860
An animal model for acute and persistent Epstein-Barr virus infection
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
An animal model for acute and persistent Epstein-Barr virus infection
@ast
An animal model for acute and persistent Epstein-Barr virus infection
@en
An animal model for acute and persistent Epstein-Barr virus infection
@nl
type
label
An animal model for acute and persistent Epstein-Barr virus infection
@ast
An animal model for acute and persistent Epstein-Barr virus infection
@en
An animal model for acute and persistent Epstein-Barr virus infection
@nl
prefLabel
An animal model for acute and persistent Epstein-Barr virus infection
@ast
An animal model for acute and persistent Epstein-Barr virus infection
@en
An animal model for acute and persistent Epstein-Barr virus infection
@nl
P2093
P1433
P1476
An animal model for acute and persistent Epstein-Barr virus infection
@en
P2093
A Moghaddam
D Lee-Parritz
M Rosenzweig
R P Johnson
P304
P356
10.1126/SCIENCE.276.5321.2030
P407
P577
1997-06-27T00:00:00Z